Cargando…
Do Value Thresholds for Oncology Drugs Differ from Nononcology Drugs?
BACKGROUND: In the past decade, many oncologic drugs have been approved that extend life and/or improve patients’ quality of life. However, new cancer drugs are often associated with high price and increased medical spending. For example, in 2010, the average annual cost of care for breast cancer in...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441029/ https://www.ncbi.nlm.nih.gov/pubmed/25351969 http://dx.doi.org/10.18553/jmcp.2014.20.11.1086 |